tradingkey.logo

Harvard Bioscience Inc

HBIO

0.469USD

-0.015-3.04%
Close 09/19, 16:00ETQuotes delayed by 15 min
20.87MMarket Cap
LossP/E TTM

Harvard Bioscience Inc

0.469

-0.015-3.04%
More Details of Harvard Bioscience Inc Company
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Company Info
Ticker SymbolHBIO
Company nameHarvard Bioscience Inc
IPO dateOct 21, 2013
CEOMr. John D. Duke
Number of employees330
Security typeOrdinary Share
Fiscal year-endOct 21
Address84 October Hill Rd
CityHOLLISTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code01746-1371
Phone15088938999
Websitehttps://www.harvardbioscience.com/
Ticker SymbolHBIO
IPO dateOct 21, 2013
CEOMr. John D. Duke
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
By RegionUSD
Name
Revenue
Proportion
United States
9.83M
45.13%
Europe, Middle East and Africa
6.03M
27.69%
China
2.73M
12.56%
Rest of Asia
2.35M
10.81%
Americas - Other
829.00K
3.81%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
AMH Equity, Ltd.
9.09%
Weber Capital Management, LLC
7.19%
Harvey Partners, LLC
4.81%
The Vanguard Group, Inc.
4.16%
Green (James W)
3.68%
Other
71.08%
Shareholders
Shareholders
Proportion
AMH Equity, Ltd.
9.09%
Weber Capital Management, LLC
7.19%
Harvey Partners, LLC
4.81%
The Vanguard Group, Inc.
4.16%
Green (James W)
3.68%
Other
71.08%
Shareholder Types
Shareholders
Proportion
Hedge Fund
18.23%
Investment Advisor
16.06%
Investment Advisor/Hedge Fund
13.83%
Individual Investor
10.26%
Venture Capital
7.21%
Pension Fund
2.04%
Research Firm
0.81%
Family Office
0.07%
Bank and Trust
0.01%
Other
31.46%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
214
34.64M
78.35%
-7.01M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
2023Q2
223
36.47M
86.49%
-881.53K
2023Q1
220
35.48M
86.11%
-356.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
AMH Equity, Ltd.
3.60M
8.14%
-170.35K
-4.52%
May 29, 2025
Weber Capital Management, LLC
3.20M
7.24%
+683.45K
+27.15%
Mar 31, 2025
Harvey Partners, LLC
2.19M
4.95%
-495.50K
-18.47%
Mar 31, 2025
The Vanguard Group, Inc.
2.14M
4.84%
-19.11K
-0.89%
Mar 31, 2025
Green (James W)
2.03M
4.59%
+348.61K
+20.74%
Mar 20, 2025
272 Capital LLC
1.56M
3.52%
+1.56M
--
Sep 30, 2024
Granahan Investment Management, LLC
1.53M
3.46%
-89.28K
-5.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.44M
3.25%
-227.31K
-13.65%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.54M
5.75%
-164.85K
-6.09%
Mar 31, 2025
Acadian Asset Management LLC
1.08M
2.44%
+78.28K
+7.84%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI